Key result
TRIM26 acts as a protective or detrimental host factor during viral infections by modulating immune responses.
Why the study?
To review and understand the mechanisms of TRIM26 during viral infection and explore its potential future applications.
This review summarizes the mechanisms of TRIM26 during viral infection and its potential future applications.
TRIM26 modulation should not yet alter clinical antiviral strategies; leaves open targeted validation in human infection models.
(TRIM26) is an E3 ubiquitin ligase and a member of the TRIM family. Similar to other TRIM proteins, TRIM26 consists of three domains, collectively termed RBCC: a Really Interesting New Gene (RING) domain, one B-Box domain, and a C terminal domain consisting of a PRY/SPRY domain. The PRY/SPRY domain exhibits relatively higher conservation compared with the RING and B-Box domains, suggesting potentially similar roles across TRIM26 proteins from various species. TRIM26 either directly interacts with viral proteins or modulates immune responses to engage with a viral infection, serving as either a protective or detrimental host factor depending on the circumvent of the viral infection. The present review focuses on understanding the mechanisms of TRIM26 during viral infection and its potential future applications.
No takes yet. Share an insight, caveat, or question.
Sharma et al. (2024) conducted a review in Viral infection. TRIM26 was evaluated. TRIM26 serves as either a protective or detrimental host factor during viral infection by directly interacting with viral proteins or modulating immune responses.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: